Lee FY - Search Results

1

YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase.

Wu CC, Ko FN, Kuo SC, Lee FY, Teng CM. Wu CC, et al. Among authors: lee fy. Br J Pharmacol. 1995 Oct;116(3):1973-8. doi: 10.1111/j.1476-5381.1995.tb16400.x. Br J Pharmacol. 1995. PMID: 8640334 Free PMC article.

2

YC-1 attenuates LPS-induced proinflammatory responses and activation of nuclear factor-kappaB in microglia.

Lu DY, Tang CH, Liou HC, Teng CM, Jeng KC, Kuo SC, Lee FY, Fu WM. Lu DY, et al. Among authors: lee fy. Br J Pharmacol. 2007 Jun;151(3):396-405. doi: 10.1038/sj.bjp.0707187. Epub 2007 Apr 2. Br J Pharmacol. 2007. PMID: 17401444 Free PMC article.

3

YC-1, a novel activator of platelet guanylate cyclase.

Ko FN, Wu CC, Kuo SC, Lee FY, Teng CM. Ko FN, et al. Among authors: lee fy. Blood. 1994 Dec 15;84(12):4226-33. Blood. 1994. PMID: 7527671 Free article.

4

YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice.

Teng CM, Wu CC, Ko FN, Lee FY, Kuo SC. Teng CM, et al. Among authors: lee fy. Eur J Pharmacol. 1997 Feb 12;320(2-3):161-6. doi: 10.1016/s0014-2999(96)00911-9. Eur J Pharmacol. 1997. PMID: 9059849

5

YC-1 potentiates the antiplatelet effect of hydrogen peroxide via sensitization of soluble guanylate cyclase.

Wu CC, Kuo SC, Lee FY, Teng CM. Wu CC, et al. Among authors: lee fy. Eur J Pharmacol. 1999 Sep 24;381(2-3):185-91. doi: 10.1016/s0014-2999(99)00577-4. Eur J Pharmacol. 1999. PMID: 10554886

6

YD-3, a novel inhibitor of protease-induced platelet activation.

Wu CC, Huang SW, Hwang TL, Kuo SC, Lee FY, Teng CM. Wu CC, et al. Among authors: lee fy. Br J Pharmacol. 2000 Jul;130(6):1289-96. doi: 10.1038/sj.bjp.0703437. Br J Pharmacol. 2000. PMID: 10903968 Free PMC article.

7

YC-1 induces apoptosis of human renal carcinoma A498 cells in vitro and in vivo through activation of the JNK pathway.

Wu SY, Pan SL, Chen TH, Liao CH, Huang DY, Guh JH, Chang YL, Kuo SC, Lee FY, Teng CM. Wu SY, et al. Among authors: lee fy. Br J Pharmacol. 2008 Oct;155(4):505-13. doi: 10.1038/bjp.2008.292. Epub 2008 Jul 21. Br J Pharmacol. 2008. PMID: 18641674 Free PMC article.

8

YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia.

Sun HL, Liu YN, Huang YT, Pan SL, Huang DY, Guh JH, Lee FY, Kuo SC, Teng CM. Sun HL, et al. Among authors: lee fy. Oncogene. 2007 Jun 7;26(27):3941-51. doi: 10.1038/sj.onc.1210169. Epub 2007 Jan 8. Oncogene. 2007. PMID: 17213816

9

Mechanism of anti-proliferation caused by YC-1, an indazole derivative, in cultured rat A10 vascular smooth-muscle cells.

Yu SM, Cheng ZJ, Guh JH, Lee FY, Kuo SC. Yu SM, et al. Among authors: lee fy. Biochem J. 1995 Mar 15;306 ( Pt 3)(Pt 3):787-92. doi: 10.1042/bj3060787. Biochem J. 1995. Retraction in: Biochem J. 1998 Oct 1;335 ( Pt 1):191. doi: 10.1042/bj3350191 PMID: 7702575 Free PMC article. Retracted.

10

Synthesis of 1-benzyl-3-(5'-hydroxymethyl-2'-furyl)indazole analogues as novel antiplatelet agents.

Lee FY, Lien JC, Huang LJ, Huang TM, Tsai SC, Teng CM, Wu CC, Cheng FC, Kuo SC. Lee FY, et al. J Med Chem. 2001 Oct 25;44(22):3746-9. doi: 10.1021/jm010001h. J Med Chem. 2001. PMID: 11606139

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,042 results

Search Page

Filters